DrugInfoSys

Fluvoxamine (Maleate)

Drug #322

Fluvoxamine (Maleate) is antidepressant drug and belongs to SSRIs (selective serotinin reuptake inhibitors) and is used in the treatment of obsessive compulsive disorders. Fluvoxamine (Maleate) is also used for depression. Fluvoxamine (Maleate) is less effective than fluoxetine in treating depression.

Primary Characteristics

It is of Synthetic origin and belongs to Valerophenone.

It belongs to Amine uptake inhibitor pharmacological group on the basis of mechanism of action and also classified in Antidepressant pharmacological group. It is also classified under Psychotherapeutic Drugs .

Molecular Weight: 434.4 · pKa: 8.7 · Solubility in Water: sparingly · Solubility in Alcohol: freely · Non-proprietary name: Fluvoxamine (Maleate).

Molecular structure of Fluvoxamine (Maleate)

Pharmacokinetics

Absorption: Fluvoxamine (Maleate) has an oral bioavailability is 92.5% (±2.5%).

Distribution: Fluvoxamine (Maleate) has a volume of distribution is 5 l/kg. plasma protein binding is 77%.

Elimination: it is metabolised via complete, plasma half-life is 15 hr, renal excretion is major.

Advertisement

Indications

Fluvoxamine (Maleate) is primarily indicated in conditions like Depression, Depressive illness, Obsessive-compulsive disorders.

Contraindications

None recorded.

Dosage

Fluvoxamine (Maleate)'s dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
75 mg75 mgEvery 24hPOIn the evening.
Paediatric Dosage (20kg)
0 – 0Not Recommended in this Age Group
Neonatal Dosage (3kg)
0 – 0Not recommended in this age group

Drug Interactions

Unknown11 interactions
4 interactions
Major4 interactions
Moderate2 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Fluvoxamine (Maleate) in overdosage may give rise to further complications which include Increased hepatic enzymes .

Fluvoxamine (Maleate) is known to cause more or less tolerable side effects which are usually transient. These include Agitation , Anorexia , Asthenia , Diarrhea, Hypokinesia , Nausea, SomnolenceX, Tremor, Vomiting .

Warnings / Precautions

Fluvoxamine should be used with caution in patients with history of seizures, heart disease, kidney disease, liver disease or if have any allergy. This medication should be used only if clearly needed during pregnancy or lactation.

Interference in Pathology

Fluvoxamine (Maleate) may interfere in the diagnosis of Urinanalysis .

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Fluvoxamine (Maleate) should be stored Tab.

Drug Classification

  1. 1.24.2.1Drugs used in depression

Manufacturers

Manufacturers of Fluvoxamine (Maleate) in Pakistan: